- EMA Recommends Granting a Marketing Authorisation for Trastuzumab Biosimilar
- ESMO Press Release: ESMO announces new interim Editor-in-Chief of Annals of Oncology
- EMA Recommends Granting a Marketing Authorisation for Niraparib
- FDA Approves a Biosimilar to Bevacizumab
- Sarcoma & GIST 2018: Programme
- Questionnaire Designed for Adolescent and Young Adults with Cancer Elicits Their Views on Treatment
Leading the Debate on the Advances in Healthcare